TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Quarterly Activities and Cashflow Report - March 2026
Regeneron Reports First Quarter 2026 Financial and Operating Results
Delek Logistics Reports First Quarter 2026 Results
Babcock & Wilcox Secures $21 Million for Fuel Switching Technology Awards; Parts and Services Continues Strong Performance Driven by Increased Baseload Demand
Central Pacific Financial Reports First Quarter 2026 Earnings of $20.7 Million
SOLAI Limited Announces Changes to Board of Directors
Costamare Inc. Reports Results For The First Quarter Ended March 31, 2026
GE HealthCare reports first quarter 2026 financial results
GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth